Patents by Inventor Mark W. Webster

Mark W. Webster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE
    Publication number: 20200138795
    Abstract: The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent.
    Type: Application
    Filed: May 9, 2019
    Publication date: May 7, 2020
    Inventors: Patrick A. Gladding, Marja-Liisa Dahl, Mark W. Webster
  • METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE
    Publication number: 20140206716
    Abstract: The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent.
    Type: Application
    Filed: January 8, 2014
    Publication date: July 24, 2014
    Applicant: Theranostics Laboratory
    Inventors: Patrick A. Gladding, Marja-Liisa Dahl, Mark W. Webster
  • METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE
    Publication number: 20130096026
    Abstract: The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent.
    Type: Application
    Filed: December 12, 2012
    Publication date: April 18, 2013
    Inventors: Patrick A. Gladding, Marja-Liisa Dahl, Mark W. Webster
  • METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE
    Publication number: 20130096153
    Abstract: The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent.
    Type: Application
    Filed: December 12, 2012
    Publication date: April 18, 2013
    Inventors: Patrick A. Gladding, Mark W. Webster
  • METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE
    Publication number: 20130096154
    Abstract: The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent.
    Type: Application
    Filed: December 12, 2012
    Publication date: April 18, 2013
    Inventors: Patrick A. Gladding, Marja-Liisa Dahl, Mark W. Webster
  • Methods for the assessment of drug response
    Patent number: 8084210
    Abstract: The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent. Nucleotide probes and primers, kits, and microarrays suitable for such assessment are also provided.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: December 27, 2011
    Assignee: Theranostics Laboratory
    Inventors: Patrick A. Gladding, Arzu Gunes, Marja-Liisa Dahl, Mark W. Webster
  • METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE
    Publication number: 20110060532
    Abstract: The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent.
    Type: Application
    Filed: November 19, 2010
    Publication date: March 10, 2011
    Applicant: THERANOSTICS LABORATORY
    Inventors: Patrick A. Gladding, Arzu Gunes, Marja-Liisa Dahl, Mark W. Webster